Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Schlessinger

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Nature|November 25, 2021
Mechanism for the activation of the anaplastic lymphoma kinase receptorAndrey V Reshetnyak, Paolo Rossi, Alexander G Myasnikov, et al.
The Journal of Cell Biology|September 12, 2007
Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) miceHava Gil-Henn, Olivier Destaing, Natalie A Sims, et al.
Journal of Medicinal Chemistry|April 25, 2020
Selective Janus Kinase 2 (JAK2) Pseudokinase Ligands with a Diaminotriazole CoreMaria-Elena Liosi, Stefan G Krimmer, Ana S Newton, et al.
Tetrahedron Letters|August 16, 2021
Indoloxytriazines as binding molecules for the JAK2 JH2 pseudokinase domain and its V617F variantAna S Newton, Maria-Elena Liosi, Sean P Henry, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2019
Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activityEkaterina S Kuzina, Peter Man-Un Ung, Jyotidarsini Mohanty, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α)Andrey V Reshetnyak, Jyotidarsini Mohanty, Francisco Tomé, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
Neuronal ALKAL2 and its ALK receptor contribute to the development of colitis-associated colorectal cancerMélissa Delanne-Cuménal, Manon Defaye, Améline Delanne-Cuménal, et al.
Molecular Biology of the Cell|April 9, 2025
Inducible FAK loss but not FAK inhibition in endothelial cells of PYK2-null mice activates p53 tumor suppressor to prevent tumor growthXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Science Signaling|January 22, 2015
Heparin is an activating ligand of the orphan receptor tyrosine kinase ALKPhillip B Murray, Irit Lax, Andrey Reshetnyak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2013
Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal regionAndrey V Reshetnyak, Bryce Nelson, Xiarong Shi, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Nature|November 25, 2021
Mechanism for the activation of the anaplastic lymphoma kinase receptorAndrey V Reshetnyak, Paolo Rossi, Alexander G Myasnikov, et al.
The Journal of Cell Biology|September 12, 2007
Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) miceHava Gil-Henn, Olivier Destaing, Natalie A Sims, et al.
Journal of Medicinal Chemistry|April 25, 2020
Selective Janus Kinase 2 (JAK2) Pseudokinase Ligands with a Diaminotriazole CoreMaria-Elena Liosi, Stefan G Krimmer, Ana S Newton, et al.
Tetrahedron Letters|August 16, 2021
Indoloxytriazines as binding molecules for the JAK2 JH2 pseudokinase domain and its V617F variantAna S Newton, Maria-Elena Liosi, Sean P Henry, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2019
Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activityEkaterina S Kuzina, Peter Man-Un Ung, Jyotidarsini Mohanty, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α)Andrey V Reshetnyak, Jyotidarsini Mohanty, Francisco Tomé, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
Neuronal ALKAL2 and its ALK receptor contribute to the development of colitis-associated colorectal cancerMélissa Delanne-Cuménal, Manon Defaye, Améline Delanne-Cuménal, et al.
Molecular Biology of the Cell|April 9, 2025
Inducible FAK loss but not FAK inhibition in endothelial cells of PYK2-null mice activates p53 tumor suppressor to prevent tumor growthXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Science Signaling|January 22, 2015
Heparin is an activating ligand of the orphan receptor tyrosine kinase ALKPhillip B Murray, Irit Lax, Andrey Reshetnyak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2013
Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal regionAndrey V Reshetnyak, Bryce Nelson, Xiarong Shi, et al.
Pageof 13